Use of CK2 inhibitor for the treatment and chemosensibilization of refractory tumors to anticancer drugs

Details for Australian Patent Application No. 2007219572 (hide)

Owner Biorec B.V. Centro de Ingenieria Genetica Y Biotecnologia

Inventors Ramos Gomez, Yassel; Perea Rodriguez, Silvio Ernesto; Castellanos Serra, Lila Rosa; Gonzalez Lopez, Luis Javier; Perera Negrin, Yasser; Acevedo Castro, Boris Ernesto; Fernandez De Cossio Dorta Duque, Jorge; Rodriguez Ulloa, Arielis; Alonso, Daniel Fernando; Gomez, Daniel Eduardo; Sanchez Puente, Aniel; Gil Valdes, Jeovanis; Betancourt Nunez, Lazaro Hiram; Besada Perez, Vladimir

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2007219572

PCT Pub. Number WO2007/098719

Priority 2006-0049 28.02.06 CU

Filing date 28 February 2007

Wipo publication date 7 September 2007

Acceptance publication date 5 July 2012

International Classifications

A61K 38/08 Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

A61K 31/00

A61P 35/00 Antineoplastic agents

Event Publications

18 September 2008 PCT application entered the National Phase

  PCT publication WO2007/098719 Priority application(s): WO2007/098719

5 July 2012 Application Accepted

  Published as AU-B-2007219572

1 November 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007219574-Arrangement comprising an object, which is at least partially composed of metal or noble metal, and an RFID identification apparatus

2007219571-Chimeric vaccine antigens against the avian influenza virus